HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation/Legislation (Cosmetics)

Regulation

Set Alert for Regulation (Beauty)

Latest From Beauty & Regulation

US FDA Pushing For Cosmetics Industry Cooperation On Allergens, Other Priorities

The FDA’s Center for Food Safety and Applied Nutrition has a wish list for cosmetics reform legislation, but with Congress currently focused elsewhere, the agency is using its existing authority and resources to address cosmetics safety priorities while working to drive voluntary industry support.

United States FDA

Including Oxybenzone, Octinoxate On US Sunscreen Monograph Could Swing On Environmental Impact

FDA will prepare an environmental impact statement on sunscreen ingredients oxybenzone and octinoxate in light of questions on the ingredients’ impact on coral and coral reefs. It plans to complete the review prior to publishing final order for its OTC sunscreen ingredients monograph.

OTC Drugs FDA

California VOC Limits Will Challenge Industry To Maintain Fragrance Quality, Consumer Acceptance

The Fragrance Creators Association and Personal Care Products Council remain concerned that more stringent VOC limits for personal fragrance products in California, as approved by the Air Resources Board in March, will be disproportionately burdensome for industry and potentially detrimental to the market.

US States Regulation

Woodcock: COVID-19 Pandemic Is Not The Time For Structural Changes At US FDA

Acting FDA Commissioner Janet Woodcock says FDA is interested in establishing new ‘Centers of Excellence’ but the current environment is not the right time to make changes at the agency. Woodcock also talked about where FDA will spend its new pandemic money and its reexamination of accelerated approval drugs in a wide-sweeping conversation with the Alliance for a Stronger FDA.

FDA Coronavirus COVID-19

ACI’s Antiseptic Testing Continues Under Specter Of FDA Administrative Order

The American Cleaning Institute is preparing to submit a healthcare personnel hand wash study to the US FDA pending confidentiality discussions, along with results from a literature review on the topic of antimicrobial resistance. A progress report is due to the agency in October, which could stave off an administrative order under the reformed OTC drug review system.

FDA Regulation

Has COVID Changed US FDA’s Thinking About OTC Antiseptics?

The public health emergency has shown that the US needs more hand sanitizers on store shelves, not less, right?

United States Regulation
See All

Legislation

Set Alert for Legislation (Beauty)

Latest From Beauty & Legislation

Including Oxybenzone, Octinoxate On US Sunscreen Monograph Could Swing On Environmental Impact

FDA will prepare an environmental impact statement on sunscreen ingredients oxybenzone and octinoxate in light of questions on the ingredients’ impact on coral and coral reefs. It plans to complete the review prior to publishing final order for its OTC sunscreen ingredients monograph.

OTC Drugs FDA

FTC Will Ask Congress To Sharpen Monetary Relief Authority Dulled By Supreme Court Ruling

Justice Breyer suggests FTC ask Congress to strengthen its enforcement rules. It is “free to ask Congress to grant it further remedial authority,” according to court opinion stating a rule the FTC has wielded for forty years to impose financial penalties doesn’t grant it authority to obtain equitable monetary relief.

Ad Complaints Legal Issues

NGO Highlights ‘Toxic’ Cleaning Product Chemicals Disclosed In California; Next Up, Personal Care

Women’s Voices for the Earth says California’s Cleaning Product Right to Know Act, which influenced similar legislation enacted last year for cosmetic fragrance and flavor ingredients, has revealed toxic substances long hidden from the general public that disproportionately impact marginalized groups.

Legislation Cosmetic Ingredients

Funding For US FDA Work On Cannabinoids Regulatory Pathway Drives Progress Only So Far

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

Cannabidiol CBD FDA

Legislating US Regulatory Pathway For Cannabinoids ‘Not End of The World’ – Gottlieb

Former FDA commissioner says legislative carve-out for a regulatory pathway for cannabinoids is a better option than a rulemaking, which could take five years and “may not even work.” Cannabinoids market is “well far ahead of where the regulation is,” he says.

Cannabidiol CBD FDA

Sun Setting On Attempts To Expand Hawaii Sunscreen Ingredient Ban During 2021

Advocates hoped a study suggesting octocrylene in sunscreens may degrade into benzophenone would convince lawmakers to expand ban, but a House committee maintained its commitment to wait on more research.

Cosmetics Legislation
See All

Litigation

Set Alert for Litigation (Beauty)

Latest From Beauty & Legal Issues

US Plaintiffs Branching From Natural To Clean-Type Claims, Attorneys Warn At PCPC Virtual Summit

Are botanical claims equivalent to natural claims? Can hair truly be repaired? What constitutes “oil-free”? Such are the questions raised in growing litigation against cosmetic product companies under consumer protection statutes around the US, Conkle, Kremer & Engel attorneys say.

United States Legal Issues

California Federal Court Rejects Settlement Proposal In Coppertone ‘Mineral-Based’ Sunscreen Case

Beiersdorf and former owner Bayer are on the verge of settling a proposed class action in California’s Northern District challenging “mineral-based” claims on Coppertone sunscreens that also contain chemical UV filters. However, the parties will have to try again with their proposed terms.

United States Advertising, Marketing & Sales

Owner Of Sunscreen Testing Lab AMA Awaits Sentencing Following Guilty Plea In US Federal Case

Gabriel Letizia Jr. potentially faces up to seven years in prison after admitting to defrauding AMA Laboratories customers of more than $46m by sending them bogus testing reports. The US FDA, which participated in the investigation, has not commented publicly on the implications for improperly tested sunscreens and other products.

United States Legal Issues

Congressional Split Looms Over Including Retroactive Reach In FTC Monetary Relief Authority

Lawmakers disagree whether legislation to amend an FTC regulation to grant the commission authority to pursue monetary remedies should be retroactive, which would impact approximately 75 pending federal court cases alleging violations.

Politics Ad Complaints

FTC Will Ask Congress To Sharpen Monetary Relief Authority Dulled By Supreme Court Ruling

Justice Breyer suggests FTC ask Congress to strengthen its enforcement rules. It is “free to ask Congress to grant it further remedial authority,” according to court opinion stating a rule the FTC has wielded for forty years to impose financial penalties doesn’t grant it authority to obtain equitable monetary relief.

Ad Complaints Legal Issues

Alibaba's Unprecedented $2.8bn Fine Could Signal Start Of Antitrust Wave In China

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

E-Commerce Enforcement
See All
UsernamePublicRestriction

Register